Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis
Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis
isPeerReviewed
numberOfPages
abstract
<p>The lack of registered drug ...... etiology and drug targets.</p>
@en
authorList
type
label
Engineered human hepatocyte or ...... d drug screening for steatosis
category
electronicVersions
externalOrganisations
journalAssociation
journalNumber
keywordGroups
language
managingOrganisationalUnit
openAccessPermission
organisationalUnits
publicationStatuses
submissionYear
totalScopusCitations
visibility
Publiek - Geen beperking
@nl
workflow
Validated
@en